Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Sweetgreen Inc (NYSE: SG) is trading higher Friday after the company reported better-than-expected top-line financial results and issued guidance above estimates.
Gainers
Statera Biopharma, Inc. (NASDAQ: STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19.
Sweetgreen (NYSE:SG) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(0.66) by 72.73 percent. The company reported quarterly sales of $96.40 million which beat the analyst